The companies have presented positive Phase II data during an oral session at ID...
The UK’s National Institute of Health and Care Excellence (NICE) said the drug p...
In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the ben...
FibroBiologics has entered a master services agreement with Charles River Labora...
A partial hold was placed on the trial after results showed variance between squ...
Astellas Pharma has received approval from the FDA for VYLOY in conjunction with...
GSK has announced a £50m ($54.3m) investment in a partnership with the Universit...
As a companion diagnostic, Oncomine will be used to identify patients eligible f...
This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to rest...
A stake by France-owned Bpifrance and promise of local job retention have allaye...
Arcutis Canada, has received Health Canada's approval for ZORYVE to treat seborr...
The funding will support Seaport’s technology platform, which helps drugs be abs...
TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (be...
A potential three-year framework agreement between the Greek government and the ...
Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enha...
Late-stage pipeline products could drive combined sales of approximately $171.4 ...